ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report)’s share price crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.01 and traded as high as $0.0108. ProtoKinetix shares last traded at $0.0052, with a volume of 1,665,000 shares.
ProtoKinetix Stock Down 47.5%
The business’s 50 day moving average price is $0.01 and its 200-day moving average price is $0.01.
ProtoKinetix Company Profile
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc and changed its name to ProtoKinetix, Incorporated in July 2003.
Featured Articles
- Five stocks we like better than ProtoKinetix
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
